ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Creative Proteomics Announces Its Newly-developed Five Glycomics Services for Protein Scientists

SHIRLEY, NY - Mar 25, 2019 - Creative Proteomics, a leading supplier in drug development services, has recently released its newly-developed five glycomics services to researchers. The service ranges include five: N-glycan profiling, O-glycan profiling, N-glycosylation site occupation analysis, O-glycosylation site occupation analysis, and glycopeptides analysis.

With the increasing use of protein therapeutics such as monoclonal antibodies, glycoproteins, hormones, cytokines and coagulation factors in clinical practice, routine monitoring of N-glycan profiling of proteins has become increasingly popular. At Creative Proteomics, MALDI-TOF MS and HILIC-UHPLC MS can be used for N-Glycan profiling.

Unlike N-glycans, there are no known O-linked amino acid consensus sequences. The O-glycans are structurally diverse. They can be divided into several structural families with relatively heterogeneous core structures. Creative Proteomics typically utilizes MALDI-TOF MS for O-glycan profiling. This allows MALDI TOF MS to analyze all O-glycans in the positive mode. Direct injection of O-glycans of permethylation into the mass spectrometer can provide information about the glycans composition.

N-glycosylation site occupation analysis is a physiological feature of glycoproteins and primarily contributes N-glycan macroheterogeneity. Characterizing the site-specific N-glycosylation including N-glycosylation site occupancy and site-specific glycan structure is important for an understanding of glycoprotein biosynthesis and function. In Creative Proteomics, general analytical strategies for variable N-glycosylation site occupancy include protein digestion, glycan release, separation of glibenclamide by liquid chromatography, and detection by mass spectrometry. There are also a couple of labeling or label-free quantitative approaches to quantify N-glycosylation site occupancy by using LC-MS/MS. 

O-linked glycans are generally much smaller than N-linked glycans and can be varied. They may also attach proteins at more likely sites, which increases the complexity of the analysis. Therefore, it is difficult to determine the exact position of O-glycosylation. Creative Proteomics can perform a high-quality O-glycosylation site occupation analysis.

Glycopeptides analysis provides very useful information about glycans on one or more proteins. It can be used to discover and characterize some novel and interesting molecules that lead to the development of new products. Comparing glycopeptides analysis can help diagnose or treat disease and is also beneficial for a better understanding of disease progression and pathology.

“Creative Proteomics is committed to providing high-quality and cost-effective services and products to laboratories and research institutes. Our newly-developed glycomics services are customized to meet the needs of our customers who believe in our scientists and Creative Proteomics”, said Dr. Charlie.

About Creative Proteomics

Creative Proteomics, as a professional glycomics services supplier, has been equipped with advanced technologies to meet the growing needs of researchers and scientists in proteomics and metabolomics glycomics related researches.

Media Contact
Company Name: Creative Proteomics
Contact Person: Dora West
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-proteomics.com



Source: www.abnewswire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.